Literature DB >> 12840963

An observational study of intravenous medication errors in the United Kingdom and in Germany.

Veronika Wirtz1, Katja Taxis, Nick D Barber.   

Abstract

OBJECTIVES: To investigate the incidence and the severity of intravenous (i.v.) drug preparation and administration errors in two countries and three pharmacy services.
METHOD: A disguised observational method was used to record details of the preparation and administration of prescribed i.v. drugs on two wards in each of three teaching hospitals: one with a traditional British ward pharmacy service (TBP) and two hospitals in Germany, one with a traditional ward stock supply (TGP) and one with a satellite pharmacy service (GSP) with unit dose system. MAIN OUTCOME MEASURES: Errors in i.v. drug preparation and administration and their potential significance.
RESULTS: The number of observed preparations/administrations were: TBP 77/63, TGP 126/109 and GSP 134/106. The preparation error rates were: TBP 22% (95% confidence interval: 13-31%), TGP 23% (16-30%) and GSP 31% (23-39%). The administration error rates were TBP 27% (16-38%), TGP 49% (39-58%) and GSP 22% (14-30%). The percentage of administration errors on the wards with TGP was statistically significantly higher than in the other two services. Common errors at the study sites with TBP and GSP were omissions. Wrong rate of administration occurred most frequently on the wards with TGP. The majority of errors were likely to be of 'moderate' to 'severe' outcome. Careful drug chart reading could possibly reduce omission errors on the wards with TBP. A change of the German nursing law ('Krankenpflegegesetz') to legally entitle nurses to administer i.v. drugs could probably result in better training, national guidelines and standards.
CONCLUSION: This study found a high rate of i.v. medication errors of moderate to severe significance. Changes in practice should be considered to make i.v. therapy safer for patients.

Entities:  

Mesh:

Year:  2003        PMID: 12840963     DOI: 10.1023/a:1024009000113

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  11 in total

1.  Validity and reliability of observational methods for studying medication administration errors.

Authors:  B Dean; N Barber
Journal:  Am J Health Syst Pharm       Date:  2001-01-01       Impact factor: 2.637

2.  Evaluation of nurses' errors associated in the preparation and administration of medication in a pediatric intensive care unit.

Authors:  M P Schneider; J Cotting; A Pannatier
Journal:  Pharm World Sci       Date:  1998-08

3.  Medication errors in a nurse-controlled parenteral admixture program.

Authors:  M P Thur; W A Miller; C J Latiolais
Journal:  Am J Hosp Pharm       Date:  1972-04

4.  Hospital drug distribution systems in the UK and Germany--a study of medication errors.

Authors:  K Taxis; B Dean; N Barber
Journal:  Pharm World Sci       Date:  1999-02

5.  Errors in administration of intravenous drugs.

Authors:  M C O'Hare; A M Bradley; T Gallagher; M D Shields
Journal:  BMJ       Date:  1995-06-10

6.  Comparison of medication errors in an American and a British hospital.

Authors:  B S Dean; E L Allan; N D Barber; K N Barker
Journal:  Am J Health Syst Pharm       Date:  1995-11-15       Impact factor: 2.637

7.  Survey of clinical pharmacy services in United Kingdom National Health Service hospitals.

Authors:  S M Cotter; N D Barber; M McKee
Journal:  Am J Hosp Pharm       Date:  1994-11-01

8.  Data collection techniques: observation.

Authors:  K N Barker
Journal:  Am J Hosp Pharm       Date:  1980-09

9.  Medication errors at the administration stage in an intensive care unit.

Authors:  E Tissot; C Cornette; P Demoly; M Jacquet; F Barale; G Capellier
Journal:  Intensive Care Med       Date:  1999-04       Impact factor: 17.440

Review 10.  Fundamentals of medication error research.

Authors:  E L Allan; K N Barker
Journal:  Am J Hosp Pharm       Date:  1990-03
View more
  28 in total

1.  The role of structured observational research in health care.

Authors:  J Carthey
Journal:  Qual Saf Health Care       Date:  2003-12

2.  Incidence and severity of intravenous drug errors in a German hospital.

Authors:  K Taxis; N Barber
Journal:  Eur J Clin Pharmacol       Date:  2003-10-29       Impact factor: 2.953

3.  Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units.

Authors:  Isabella De Giorgi; Bertrand Guignard; Caroline Fonzo-Christe; Pascal Bonnabry
Journal:  Pharm World Sci       Date:  2010-06-17

4.  Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France.

Authors:  D H Cousins; B Sabatier; D Begue; C Schmitt; T Hoppe-Tichy
Journal:  Qual Saf Health Care       Date:  2005-06

5.  Using the internet to deliver education on drug safety.

Authors:  B D Franklin; K O'Grady; J Parr; I Walton
Journal:  Qual Saf Health Care       Date:  2006-10

6.  Estimated cost savings from reducing errors in the preparation of sterile doses of medications.

Authors:  Terry F Urbine; Philip J Schneider
Journal:  Hosp Pharm       Date:  2014-09

7.  How much money can be saved by applying intravenous antibiotics once instead of several times a day?

Authors:  D Mertz; H Plagge; S Bassetti; M Battegay; A F Widmer
Journal:  Infection       Date:  2010-10-28       Impact factor: 3.553

8.  Council of Europe Resolution CM/Res(2016)2: a major contribution to patient safety from reconstituted injectable medicines?

Authors:  Alison M Beaney; Paul Le Brun; Silvia Ravera; Henk Scheepers
Journal:  Eur J Hosp Pharm       Date:  2019-02-16

Review 9.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 10.  A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment.

Authors:  Karin H M Larmené-Beld; Henderik W Frijlink; Katja Taxis
Journal:  Eur J Clin Pharmacol       Date:  2019-01-25       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.